Skip to main content

Author: c001os

“Hyper eyes” that can see inside eggs

Two Canadian egg organizations and a technology company have developed an in-ovo sexing technology that can be used on both white and brown eggs and will soon be marketed to egg producers.

The HyperEye technology uses a combination of hyperspectral imaging and artificial intelligence and works on all eggs as early as the fourth day of incubation. The non-invasive method has been validated in commercial hatcheries.

The HyperEye technology is stand-alone and has a small footprint, making it able to be incorporated into a hatchery’s already existing process flow. The equipment was developed by Canadian Egg Technologies, a collaboration between Egg Farmers of Ontario and Egg Farmers of Canada, and technology company MatrixSpec Solutions.

“As farmers, we understand firsthand the need to continue to evolve our approach and use new innovations to address the challenges at hand,” stated Co-Chair of Canadian Egg Technologies Roger Pelissero. “HyperEye provides a unique solution for hatcheries world-wide and can help accelerate our collective efforts in addressing a complex area of our supply chain.”

Matrixspec CEO Dr. Michael Ngadi said: “Working directly with farmers has allowed us to understand the intricacies of hatcheries and the egg supply chain. Together, we are not only addressing animal welfare concerns but also offering a practical and scalable tool that is designed to integrate seamlessly into hatcheries.”

Record year for the Polish poultry industry

Poland’s poultry industry experienced an outstanding year in 2024 as monthly production reached a record level, the National Chamber of Poultry and Feed Producers (KIPDiP) revealed.

The organisation said that monthly poultry production exceeded the threshold of 150 million heads during the year at least 3 times. “A few years ago, we wondered whether a monthly production record of over 100 million chickens could be maintained,” recalled Katarzyna Gawrońska, director of the National Chamber of Poultry and Feed Producers. “However, it quickly turned out that such a number of broilers produced on a monthly scale was not an exception but a rule for the industry. We can now celebrate achieving another milestone,” she added. The industry’s growth this year has even triggered an occasional shortage of hatching eggs.

Poland is the largest producer of poultry meat in Europe, accounting for one-fifth of the EU’s total output. Spain and Germany, ranked second and third in the list of largest manufacturers, are far behind, with 13% and 14% in the EU’s poultry supply, respectively.

Despite the general positivity, Poland’s poultry farmers express concerns over growing dependence on foreign trade, Gawrońska said. Poland’s market can consume less than half of the broiler meat the country manufactures, meaning significant shifts in demand in other EU countries – the key sales market for Poland’s broiler meat – could be quite painful for the industry.

Against this background, Gawrońska rang the alarm bell over the looming agreement between the EU and the Mercosur countries. She noted a potential devastating impact of increased poultry meat imports from Brazil to the EU, warning that it c

Can IVF technique halve dairy methane emissions?

Hilda is the first to be born in the Langhill cow herd. Located in southern Scotland, the cow has been born through IVF and specifically bred to produce less methane.

Three technologies have been used to create Hilda, including systems that can predict an individual cow’s methane production based on DNA. Eggs were also extracted for fertilisation at a younger age with semen pre-sorted for sex.

“You mix those three [technologies] together, and that enables you to accelerate female selection for reduced methane, one calf at a time,” said Mike Coffey at Scotland’s sustainability-focused Rural College, who explained repeating this process would eventually lead to a low methane herd. The ultimate goal is to create a stock that significantly reduces methane emissions.

Traditional selection of cows for dairy and meat based on these traits has brought emissions down by around 1% annually. It is believed that by adopting this tech-enabled approach the methane output of a herd would plummet by 30% over the next two decades.

The economic feasibility of such innovations remains a challenge. Today, the cost of producing Hilda is around double the economic value of the animal itself. This means government intervention could be needed to make the approach cost effective, in the same way EVs have become established through policy levers. This comes at a time when several countries are competing to cut methane emissions from livestock.

The efforts unfolding in Scotland reflect the global drive to rapidly reduce methane emissions. These technology-driven solutions could shape the future of sustainable agricultural practices worldwide.

Cystic Ovarian Disease: a threat to dairy productivity in the UK

A common disease affecting between 5% and 60% of dairy cattle in the UK, cystic ovarian disease negatively impacts cow productivity, with effects on both farm efficiency and profitability.

The disease leads to a prolonged interval between calving and conception, resulting in decreased milk production and increased culling rates. These factors collectively affect the economic sustainability of dairy farms, emphasizing the need for effective management and treatment strategies.

Veterinarians and farmers are urged to collaborate closely to mitigate the impacts of this disease through regular health monitoring and appropriate medical interventions. Cystic ovarian disease remains a critical concern for the dairy industry, demanding continued research and attention to ensure the welfare of cattle and the viability of dairy operations.

Weighing without scales wins Dutch innovation prize

The annual contest of most promising pig innovation in the Netherlands has been won by a novelty to weigh pigs using camera images, without the use of scales.

It was the 9th edition of the contest, which is officially called “Het beste idee van Varkensland” (which roughly translates to “The Best Idea in the Pig Community”). The winning innovation, developed by ICT expert Pieter Hoenderken, revolves around the use of artificial intelligence, which will help translate the dimensions of a pig into its weight – a process that can be done using fixed cameras. The intention behind the concept is to create a portable solution that the pig farmer can use to move around the barn.

Monitoring pig growth and health are important issues – as one of the main targets of producing swine is to get them to slaughter in a uniform manner. In case of deviation from the average, something may be wrong. Hence Hoenderken’s claim that the innovation can even contribute to improving pig welfare.

The technology is initially being prepared to determine the correct pig delivery weight. In the long term, it will be possible to monitor the development of pigs with the invention and link that to the management system.

EU policymakers pay attention to US university gene-editing results

Jon Oatley, a Washington State University professor in the School of Molecular Biosciences, was invited by the US Embassy in Romania to speak about his research into gene-editing livestock. But most of the questions the European policy makers asked had to do with public acceptance of the technology.

“I was invited to speak at this summit because of what we’ve been able to accomplish at WSU not just in the research world but also in the policy space. We’ve become the place in the US that everyone’s looking to for progress in this area,” said Oatley, who is also the associate dean for research at WSU’s College of Veterinary Medicine.

Oatley led the research team that developed “surrogate sires,” a gene-editing method which can help disseminate desirable and needed traits in livestock, such as better heat resilience. The technology promises to vastly improve protein sources to help feed the world’s growing population — but only if people will eat the meat from gene-edited animals.

Oatley and his team not only worked to secure Food and Drug Administration approval to put several CRISPR-modified pigs into the food chain but also ate the resulting sausage at a public cookout, inviting the media to try it themselves. This is the same goal Oatley had in Europe where policymakers are very hesitant about anything that might be considered “genetically modified.” “It’s not a concern necessarily about safety really,” Oatley said. “It’s the perception of how are we going to put something that could be considered genetically modified on to dinner plates? But we’re already doing it. We have been genetically modifying animals and crops through selective breeding for thousands of years. This is just a different tool.”

Gene editing involves working within a species’ genome to create changes in an animal or plant that could occur naturally. It often gets falsely conflated with genetic modification methods that insert foreign DNA from one species into another.

The most frequent questions Oatley received in Europe were about the potential need for labelling products, how gene-editing might affect animal welfare, and how to improve the public’s trust of science. Oatley doesn’t believe in the need for labelling meat from gene-edited animals if it has already passed safety tests as it should be on the same level as meat from selectively bred animals.

Foot-and-Mouth Disease in Germany

The Foot-and-Mouth Disease (FMD) outbreak in Germany is still confined to just one case. The virus reappeared in the country after nearly 40 years, when in early January 2025, 3 dead water buffalo tested positive on a farm 20 kilometres from Berlin (in Hoppegarten, Brandenburg). As a precaution, all other 11 water buffalo on the organic farm were culled, as well as animals on farms within a 1 km radius, which included 170 pigs. A week later there was panic that the virus may have emerged at a 2nd location in a nearby goat farm, but tests revealed that samples tested negative for FMD virus.

In the Barnim district, about 15 km from the location of the outbreak, goats on a hobby farm had been found with blisters in their mouths. Those animals were culled on Wednesday. The German reference lab, Friedrich-Loeffler-Institute, reported on Friday morning that the animals did not carry the virus nor had antibodies against FMD virus.

Cem Özdemir, Germany’s federal minister of agriculture, was quoted to be upbeat about the fact that no further spread was demonstrated, but emphasised to continue being vigilant. He told the radio station Deutschlandfunk: “Germany isn’t free of FMD.” However, there is nothing to prevent milk and meat products from being sold outside of the restricted zones, he emphasised.

The country was seeking crisis aid for farmers from the EU and was also in talks with its finance ministry, he said.

Pig prices in the country have stabilised as fears subsided that foot-and-mouth disease would spread, while the EU has indicated that German meat and dairy product sales outside the region containing the case could continue.

Some emergency measures to restrict spread of the highly infectious disease, which poses no danger to humans, were lifted but quarantine zones remain in force.

Measures to contain the disease often involve bans on imports of meat and dairy products from affected countries. The UK, South Korea and Mexico imposed import bans on Germany, with the British decision causing pain to Germany’s livestock sector.

German animal disease research institute Friedrich Loeffler has said th

Low-cost treatment for cow uterine infections

A sugar solution already used in some medical applications could reduce the use — and cost — of antibiotics when treating a common uterine infection in dairy cows, according to new research from The Pennsylvania State University. In the study, researchers treated cows with clinical metritis using either the antibiotic ceftiofur, or by draining the infected uterine fluid and then flushing with a sugar solution called dextrose. Both treatments appeared to be equally effective in treating the infection, though the antibiotics appeared to outperform the dextrose in cows with the most serious infections, according to Adrian Barragan, an associate research professor at Penn State.

Over the course of the trial, Barragan estimated that the average cost of the dextrose treatment ran about US$60 per cow, compared with US$340 for the antibiotic treatment. Dextrose solution, a form of glucose, is a commercially available product that is already used to treat conditions such as ketosis and downer cow syndrome, Barragan said. But researchers have suspected that it could have other applications for some time. Trial results, however, have been mixed.

In a 2016 study conducted by Barragan as part of his master’s thesis, dextrose proved promising in treating milder, sub-clinical forms of metritis. Cows with infections this mild typically recover on their own, Barragan said. So in a follow-up study, Barragan’s team attempted to use dextrose as a preventative treatment in cows at risk of developing metritis. Here, administering dextrose actually increased the odds that a cow would ultimately develop the infection, Barragan said. In cows that have yet to develop an infection, flushing the uterus with dextrose might effectively feed the bacteria that are present, Barragan said. This could occur because the healthy fluids present in the uterus prevent the dextrose from reaching concentrations needed to kill bacteria by dehydration — as seen in the most recent study where dextrose proved effective against active, clinical-level infections.

Dextrose might also aid in the treatment of other kinds of infections, such as mastitis, and this warrants further study, Barragan said. And Barragan noted that even though the results of the recent Penn State trial were unexpectedly promising, they also don’t suggest that producers could dispense with antibiotic treatments in all cases. The study’s sample size was relatively small, he said, and while the cows with more moderate symptoms made a full recovery, those with the most severe symptoms showed signs of decreased productivity when treated with dextrose alone.

Our partner’s Svájcer Paraszt Sajt has been named the best cheese of the year!

The Hungarian Cheese Makers’ Association organized the Hungarian Cheese Muster for the 12th time, the most prestigious competition for small-scale and artisanal cheesemakers in Hungary. For the first time in the event’s history, the best cheesemakers gathered in Martonvásár, where a professional conference and a cheese market accompanied the Cheese of the Year competition and the judging process.

This year, 47 cheesemakers entered the competition with a total of 114 products. The 35-member jury awarded the best cheeses and their makers with 9 gold, 22 silver, and 9 bronze medals.

The winner of the competition was the Svájcer Paraszt Sajt, produced in Dunaharaszti at our partner Árpád Ficsor’s farm. This hard cheese, aged for 18 months, is made from Hungarian Simmental cow’s milk, giving it a rich and unique flavor profile.

“My grandfather used to call the Hungarian Simmental cow a Svájcer cow. We named this cheese in his memory. The Svájcer is a surprise: it delivers an intense taste experience even after just four months of aging, and as time passes, its character becomes even stronger. From the 8th month onwards, protein crystals begin to form in the cheese.” – said Árpád Ficsor, whose Paraszt Sajt Extra Aged Svájcer also received a gold certification.

Congratulations on this fantastic achievement, and we wish you continued success!

Pig research paves way for human respiratory vaccine development

A study in pigs, which shows that inhaled vaccines could potentially reduce viral transmission and improve efficiency, is an important step toward advancing vaccines for human use.

Interest in administering vaccines mucosally, rather than by intramuscular injections, has been growing since the SARS-CoV-2 pandemic was declared in 2020. English scientists used pigs as a model to explore immune system responses to mucosally-administered flu vaccines, which target viruses at the point of entry. Comprehensive measurement of immune responses in human lungs is not possible. To overcome this challenge, the researchers used pigs – whose respiratory tract is anatomically and functionally similar to that of humans – as a model to define key immune responses. Samples collected from both the lungs and blood of vaccinated pigs, aided by mathematical modelling, showed that lung responses can be predicted from blood tests, making it easier to assess vaccine effectiveness in humans.

“To bring future vaccines to market, it is critical to define the correlates of protection – markers that can reliably predict the effectiveness of the vaccine, in humans. Our study explored potential assays, sampling times and sample types (such as blood and lung samples) which could define correlates of protection in humans,” Dr Simon Gubbins, Head of Transmission Biology at The Pirbright Institute, said. “The research found that immune responses in the blood could reliably reflect those in the lungs, thus offering a practical way to assess the effectiveness of vaccines targeting the respiratory system. The findings provide critical insights into how immune responses can be measured from easily accessible blood samples and are a foundation for future testing of mucosally administered vaccines in clinical trials,” said Sarah Gilbert, Professor of the University of Oxford.

The findings of this study, published today in Frontiers in Immunology have far-reaching implications for the future development of mucosally-administered vaccines in clinical trials. The pig model’s ability to closely mimic human immune responses to respiratory infections such as influenza makes it an ideal platform for testing vaccine efficacy. By defining effective biomarkers for mucosal vaccine efficacy and identifying the best ways to monitor and measure immune protection, this research lays the foundation for next generation vaccines. These could offer improved protection against respiratory viruses, benefiting public health worldwide.